ES8704875A1 - Procedimiento de producir compuestos para tratar la hiper- tension - Google Patents

Procedimiento de producir compuestos para tratar la hiper- tension

Info

Publication number
ES8704875A1
ES8704875A1 ES545175A ES545175A ES8704875A1 ES 8704875 A1 ES8704875 A1 ES 8704875A1 ES 545175 A ES545175 A ES 545175A ES 545175 A ES545175 A ES 545175A ES 8704875 A1 ES8704875 A1 ES 8704875A1
Authority
ES
Spain
Prior art keywords
formula
compound
antihypertensives
compounds
substituted dipeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES545175A
Other languages
English (en)
Other versions
ES545175A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
USV Pharmaceutical Corp
Original Assignee
USV Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by USV Pharmaceutical Corp filed Critical USV Pharmaceutical Corp
Publication of ES8704875A1 publication Critical patent/ES8704875A1/es
Publication of ES545175A0 publication Critical patent/ES545175A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE COMPUESTOS DE FORMULA (I) Y DE SUS SALES FISIOLOGICAMENTE COMPATIBLES. COMPRENDE LA REACCION DE UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA (III), EN UN DISOLVENTE INERTE, EN PRESENCIA DE UNA BASE, A UNA TEMPERATURA COMPRENDIDA ENTRE 0JC Y LA DE REFLUJO DE LA MEZCLA DE REACCION, PARA OBTENER UN COMPUESTO DE FORMULA (I), EN LAS QUE X1 Y X2 REPRESENTAN HALOGENO O AMINO, A1, A2, Y1, Y2, Z1-Z3, M1-M3, R1, R2 Y Q PUEDEN SER VARIOS TIPOS DE RADICALES Y M VALE 0-3. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE LA HIPERTENSION.
ES545175A 1983-03-16 1985-06-28 Procedimiento de producir compuestos para tratar la hiper- tension Expired ES8704875A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47580483A 1983-03-16 1983-03-16

Publications (2)

Publication Number Publication Date
ES8704875A1 true ES8704875A1 (es) 1987-05-01
ES545175A0 ES545175A0 (es) 1987-05-01

Family

ID=23889224

Family Applications (2)

Application Number Title Priority Date Filing Date
ES531077A Granted ES531077A0 (es) 1983-03-16 1984-03-16 Procedimiento de producir compuestos para tratar la hipertension
ES545175A Expired ES8704875A1 (es) 1983-03-16 1985-06-28 Procedimiento de producir compuestos para tratar la hiper- tension

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES531077A Granted ES531077A0 (es) 1983-03-16 1984-03-16 Procedimiento de producir compuestos para tratar la hipertension

Country Status (11)

Country Link
EP (1) EP0121830A3 (es)
JP (1) JPS59181247A (es)
KR (1) KR840009072A (es)
AU (1) AU2580184A (es)
DK (1) DK156484A (es)
ES (2) ES531077A0 (es)
FI (1) FI841052A7 (es)
IL (1) IL71266A0 (es)
NO (1) NO841024L (es)
NZ (1) NZ207531A (es)
ZA (1) ZA841981B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4482544A (en) * 1982-11-29 1984-11-13 Usv Pharmaceutical Corporation Compounds for treating hypertension
GB8311286D0 (en) * 1983-04-26 1983-06-02 Searle & Co Carboxyalkyl peptide derivatives
ZA843899B (en) * 1983-05-23 1984-12-24 Usv Pharma Corp Compounds for treating hypertension
EP0175266B1 (en) * 1984-09-12 1996-03-20 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antihypertensive derivatives
EP0236307B1 (en) * 1985-09-16 1991-04-17 Schering Corporation Antihypertensive agents, pharmaceutical compositions containing them and processes for the preparation of the agents and compositions
EP0183398B1 (en) * 1984-11-30 1989-04-12 FISONS plc Angiotensin converting enzyme inhibitors and their production and use as pharmaceuticals
FR2578544A1 (en) * 1985-03-11 1986-09-12 Usv Pharma Corp Antihypertension spirocyclic compounds
FR2578543B1 (fr) * 1985-03-11 1988-06-10 Usv Pharma Corp Composes spiro-amidoamino anti-hypertenseurs
AR033048A1 (es) 2001-03-19 2003-12-03 Kaneka Corp Metodo para la purificacion de la n-(1(s)-etoxicarbonil-3-fenilpropil) -l-alanina
CN105001139B (zh) * 2015-07-08 2018-03-02 南京葆赫生物技术有限公司 一种抗高血压活性肽、其制备方法及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3177130D1 (de) * 1980-08-30 1990-01-11 Hoechst Ag Aminosaeurederivate, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung.
EP0048159A3 (en) * 1980-09-17 1982-05-12 University Of Miami Novel carboxyalkyl peptides and thioethers and ethers of peptides as antihypertensive agents
EP0050800B2 (en) * 1980-10-23 1995-06-07 Schering Corporation Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
IN156096B (es) * 1981-03-19 1985-05-11 Usv Pharma Corp
NZ202903A (en) * 1981-12-29 1988-01-08 Hoechst Ag 1-- pe pyrrol-2-yl-carboxylic acid derivatives and pharmaceutical compositions
DE3378266D1 (en) * 1982-01-11 1988-11-24 Merck & Co Inc Aminoacyl-containing dipeptide derivatives useful as antihypertensives
DE3360065D1 (en) * 1982-03-08 1985-03-28 Schering Corp Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
DE3210496A1 (de) * 1982-03-23 1983-10-06 Hoechst Ag Neue derivate bicyclischer aminsaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue bicyclische aminosaeuren als zwischenstufen und verfahren zu deren herstellung
DE3211676A1 (de) * 1982-03-30 1983-10-06 Hoechst Ag Neue derivate von cycloalka (c) pyrrol-carbonsaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue cycloalka (c) pyrrol-carbonsaeuren als zwischenstufen und verfahren zu deren herstellung
US4499079A (en) * 1982-11-18 1985-02-12 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
DE3315464A1 (de) * 1983-04-28 1984-10-31 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von n-alkylierten dipeptiden und deren estern

Also Published As

Publication number Publication date
NO841024L (no) 1984-09-17
NZ207531A (en) 1986-12-05
ZA841981B (en) 1984-10-31
FI841052A0 (fi) 1984-03-15
AU2580184A (en) 1984-09-20
EP0121830A3 (en) 1986-02-05
IL71266A0 (en) 1984-06-29
DK156484A (da) 1984-09-17
ES8602631A1 (es) 1985-12-16
ES545175A0 (es) 1987-05-01
FI841052A7 (fi) 1984-09-17
KR840009072A (ko) 1984-12-24
ES531077A0 (es) 1985-12-16
DK156484D0 (da) 1984-03-15
EP0121830A2 (en) 1984-10-17
JPS59181247A (ja) 1984-10-15

Similar Documents

Publication Publication Date Title
CY1106223T1 (el) Μεθοδοι διαμορφωσης λειτουργιας σepινης/θρεονινης πρωτεϊνης κινασης με βασισμενες σε 5-αζακινοξαλινη ενωσεις
AR002012A1 (es) Un compuesto, una composicion farmaceutica que lo comprende, su uso, metodo de tratamiento terapeutico, metodo para la preparacion del compuesto.
NO902954D0 (no) Fremgangsmaate for fremstilling av substituerte kinazolinoner som angitensin ii-antagonister.
DK1094816T3 (da) Biphenylsulfonamider som dobbelte angiotensin-endothelin-receptorantagonister
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
AR003937A1 (es) Compuesto ciclico que tiene efecto antagonico al receptor de taquiquinina, proceso para producirlo y composicion farmaceutica que lo contiene.
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
AR006720A1 (es) Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende
CO4950533A1 (es) Metodos para modular la funcion proteina quinasa de serina/treonina con compuestos a base de quinazolina
NO20015226D0 (no) Tri-aryl syrederivater som PPAR reseptor ligander
DK0789578T3 (da) Inhibitorer af multikatalytisk protease
DE69413542D1 (de) Perhydroisoindolderivate als substanz p antagonisten
NO20034289D0 (no) N-(2-aryletylbenzylaminer som antagonister av 5-HT6- reseptoren
SV2003000882A (es) Inhibidores de metaloproteinasas de matriz basados en pirimidinonas fusionadas ref.pca428-01cfp/bb
TR200001312T2 (tr) Benzotiyazol protein tirozin kinaz önleyicileri.
ES8601992A1 (es) Procedimiento para preparar 2-fenil-imidazoles
EA200200510A1 (ru) 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр
BR0209149A (pt) Ftalazinonas
DE69626981D1 (de) N-(2-oxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3-yl)-3-amide
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
DK0882726T3 (da) Carbazolcarboxamider som 5-HT1F-agonister
DK0619806T3 (da) Fremstilling af substituerede piperidiner
DE69610628D1 (de) N-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3-yl)-3-amide
ES8404317A1 (es) Metodo de preparar aminoaminoacidos y analogos.
ES2037613B1 (es) Procedimiento de obtencion de nuevos derivados dipeptidicos.